Literature DB >> 19719331

Management of ascites.

Fedja A Rochling1, Rowen K Zetterman.   

Abstract

The development of ascites indicates a pathological imbalance between the production and resorption of intraperitoneal fluid. The appearance and composition of ascites are variable, based on the underlying pathophysiology. Most commonly, ascites develops in the setting of decompensated cirrhosis, peritoneal infection, carcinomatosis, congestive heart failure or a combination (mixed ascites). The diagnosis can be difficult in some patients. Management options for ascites from decompensated liver disease focus on low-sodium diets and diuretics supplemented by large-volume paracentesis, transvenous intrahepatic portosystemic shunts and liver transplantation. The development of refractory ascites, hepatic hydrothorax, hyponatraemia or hepatorenal syndrome presents unique challenges to the provider and the patient. In some of these patients, therapy with liver transplantation will be the only viable therapeutic option. The diagnosis of infectious ascites, such as tuberculosis, and carcinomatous ascites remain diagnostic and therapeutic challenges for the clinician.

Entities:  

Mesh:

Year:  2009        PMID: 19719331     DOI: 10.2165/11316390-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  186 in total

1.  Impact of endoscopic intervention in 100 patients with suspected postcholecystectomy bile leak.

Authors:  Arthur John Kaffes; Luke Hourigan; Nicolas De Luca; Karen Byth; Stephen John Williams; Michael John Bourke
Journal:  Gastrointest Endosc       Date:  2005-02       Impact factor: 9.427

2.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

3.  Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection.

Authors:  Shantanu Bhattacharjya; Jo Puleston; Brian R Davidson; James S Dooley
Journal:  Gastrointest Endosc       Date:  2003-04       Impact factor: 9.427

4.  The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients.

Authors:  J A Burger; A Ochs; K Wirth; D P Berger; R Mertelsmann; R Engelhardt; M Roessle; K Haag
Journal:  Ann Oncol       Date:  1997-02       Impact factor: 32.976

Review 5.  Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.

Authors:  Catrin Palm; Frank Pistrosch; Kay Herbrig; Peter Gross
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

Review 6.  Peritoneal and pleural sarcoidosis: an unusual association - review and clinical report.

Authors:  Santhi Iyer; Kamyar Afshar; Om P Sharma
Journal:  Curr Opin Pulm Med       Date:  2008-09       Impact factor: 3.155

7.  Treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (Sandostatin).

Authors:  I Segal; D Parekh; J Lipschitz; G Gecelter; J A Myburgh
Journal:  Digestion       Date:  1993       Impact factor: 3.216

8.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

Review 9.  Treatment of pancreatic pseudocysts, pancreatic necrosis, and pancreatic duct leaks.

Authors:  Todd H Baron
Journal:  Gastrointest Endosc Clin N Am       Date:  2007-07

10.  Abdominal tuberculosis: CT evaluation.

Authors:  D H Hulnick; A J Megibow; D P Naidich; S Hilton; K C Cho; E J Balthazar
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

View more
  4 in total

1.  Significance of the 13C-caffeine breath test for patients with cirrhosis.

Authors:  Dimitrios Konstantinou; Ekaterini Margariti; Emilia Hadziyannis; Dimitrios Pectasides; George V Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2014

Review 2.  Current approaches to the management of patients with cirrhotic ascites.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

3.  Qi Sui Zhu Shui Plaster Inhibits AQP1 and MAPK Signaling Reduces Liver Damage Induced by Cirrhotic Ascites.

Authors:  Rong Zhen Zhang; Yin Liu; Min Li; Yong Lin Huang; Zhen Heng Song
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

4.  Refractory ascites after laparoscopic cholecystectomy: a case report.

Authors:  Xiaoyun Cheng; Jin Huang; Aiming Yang; Qiang Wang
Journal:  BMC Surg       Date:  2022-08-17       Impact factor: 2.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.